https://www.coherus.com/
Coherus Oncology | Novel Combination Therapies for Cancer
Mar 17, 2026 - Coherus Oncology is a commercial-stage company advancing next-generation combination therapies to elevate what’s possible for people living with cancer.
combination therapiesoncologynovelcancer
https://pmc.ncbi.nlm.nih.gov/articles/PMC11743742/
Computational frameworks transform antagonism to synergy in optimizing combination therapies - PMC
While drug combinations are increasingly important in disease treatment, predicting their therapeutic interactions remains challenging. This review...
combination therapiescomputationalframeworkstransformantagonism
https://www.aacr.org/blog/tag/combination-therapies/
combination therapies Archives - American Association for Cancer Research (AACR)
combination therapiesamerican associationcancer researcharchivesaacr
https://www.ucsf.edu/news/2023/10/426446/do-combination-therapies-hold-hope-prostate-cancer-patients
Do Combination Therapies Hold Hope for Prostate Cancer Patients? | UC San Francisco
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
combination therapies
https://pmc.ncbi.nlm.nih.gov/articles/PMC12287794/
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A...
Pulmonary arterial hypertension (PAH) is often diagnosed in elderly patients with comorbidities. Although initial monotherapy is recommended for these...
combination therapiespulmonary arterial
https://www.aacr.org/patients-caregivers/progress-against-cancer/targeted-therapeutics-melanoma-cotellic-zelboraf/
Combination of Targeted Therapies Approved for Melanoma | The AACR
Feb 4, 2020 - The FDA approved a combination of molecularly targeted therapies for treating certain patients with melanoma. Learn more about this new treatment.
targeted therapiescombinationapprovedmelanomaaacr
https://www.mdpi.com/1420-3049/27/17/5452
Combination Anticancer Therapies Using Selected Phytochemicals
Cancer is still one of the most widespread diseases globally, it is considered a vital health challenge worldwide and one of the main barriers to long life...
combinationanticancertherapiesusingselected
https://www.wikidata.org/wiki/Q40208002
A sequential blockade strategy for the design of combination therapies to overcome oncogene...
scientific article published on November 2006
https://www.endocrine.org/news-and-advocacy/news-room/featured-science-from-endo-2021/combination-thyroid-hormone-therapies-treat-hypothyroidism-as-well-as-levothyroxine
Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine | Endocrine...
Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the...
thyroid hormonecombinationtherapiestreathypothyroidism
https://www.chop.edu/news/chop-researchers-find-effective-combination-therapies-managing-mitochondrial-disease
CHOP Researchers Find Effective Combination of Therapies for Managing Mitochondrial Disease |...
Study is first to demonstrate how one specific combinational therapy may provide measurable benefits to patients with mitochondrial respiratory chain...
chopresearchersfindeffectivecombination
https://www.doctorswithoutborders.org/latest/assessing-antimalarial-efficacy-time-change-artemisinin-based-combination-therapies-role
Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: The...
https://www.businesswire.com/news/home/20240124995130/en/New-ICON-Survey-Highlights-Importance-of-Combination-Therapies-in-Future-Obesity-Treatment
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
ICON plc today announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research.
new icon
https://menafn.com/1109654805/Althera-Laboratories-Expands-Into-Heart-Failure-Unveils-Advanced-Triple-Combination-Therapies-For-Global-Licensing
Althera Laboratories Expands Into Heart Failure, Unveils Advanced Triple-Combination Therapies For...
Althera Laboratories Expands Into Heart Failure, Unveils Advanced Triple-Combination Therapies For Global Licensing. Logo Althera Pioneering Triple-Combination...
heart failure
https://sciencedaily.com/releases/2025/01/250125152749.htm
Combination of dual-targeted therapies and chemotherapy shows high response rates in BRAF-mutated...
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib...
https://www.nationalacademies.org/projects/IOM-HCS-11-01
Facilitating Collaborations to Develop Combination Investigational Therapies
Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved...
to developfacilitatingcollaborationscombinationtherapies
https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.617935/full
Frontiers | Screening for Combination Cancer Therapies With Dynamic Fuzzy Modeling and...
Combination therapies proved to be a valuable strategy in the fight against cancer, thanks to their increased efficacy in inducing tumor cell death and in re...
frontiersscreeningcombinationcancer
https://www.prnewswire.com/news-releases/statins-market-to-2018---weak-product-pipeline-and-shift-of-focus-towards-combination-therapies-will-lead-to-erosion-of-brand-share-217419941.html
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies...
/PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/49ljmx/statins_market_to) has announced the addition of the "Statins Market...
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-05251
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With...
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy...
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-05251&r=1
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With...
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy...